Regeneron Pharmaceuticals
REGN
#286
Rank
C$98.87 B
Marketcap
$904.39
Share price
-4.06%
Change (1 day)
-30.73%
Change (1 year)

EPS for Regeneron Pharmaceuticals (REGN)

EPS in 2023 (TTM): $50.39

According to Regeneron Pharmaceuticals's latest financial reports the company's current EPS (TTM) is $53.28. In 2022 the company made an earnings per share (EPS) of $57.79 a decrease over its 2021 EPS that were of $109.03.

EPS history for Regeneron Pharmaceuticals from 1996 to 2023

Annual EPS

Year EPS Change
2023 (TTM)$50.39-12.8%
2022$57.79-47%
2021$109.03133.36%
2020$46.7269.13%
2019$27.62-14.44%
2018$32.29100.71%
2017$16.0931.78%
2016$12.2138.96%
2015$8.7972.55%
2014$5.09-17.55%
2013$6.18-44.98%
2012$11.22-422.54%
2011-$3.4892.13%
2010-$1.8149.41%
2009-$1.21-15.84%
2008-$1.44-36.88%
2007-$2.28-9.6%
2006-$2.524.12%
2005-$2.42-323.68%
2004$1.08-135.51%
2003-$3.05-24.38%
2002-$4.0456.35%
2001-$2.58187.3%
2000-$0.90-16%
1999-$1.07177.78%
1998-$0.39-35.71%
1997-$0.60-68.42%
1996-$1.90

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
$20.18-62.13%๐Ÿ‡บ๐Ÿ‡ธ USA
-$5.86-111.00%๐Ÿ‡บ๐Ÿ‡ธ USA
$26.33-50.59%๐Ÿ‡บ๐Ÿ‡ธ USA
$20.09-62.30%๐Ÿ‡บ๐Ÿ‡ธ USA
$5.33-89.99%๐Ÿ‡จ๐Ÿ‡ญ Switzerland
$4.54-91.49%๐Ÿ‡ซ๐Ÿ‡ท France